MedTrace Logo

Metacognitive Therapy for Health Anxiety

NCT02404116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-02-07

No results posted yet for this study

Summary

The study involves a comparing a new psychological treatment- Metacognitive Therapy (MCT) which has shown promising results in the treatment of health anxiety to no treatment at all- a waiting list.

Conditions

  • Hypochondriasis

Interventions

OTHER

Metacognitive Therapy

Participants will receive treatment which focus's on helping reduce excessive thinking about health,

OTHER

Wait List

Individuals are on a waiting list

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Principal Investigators

  • Robin Bailey, MSc · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02404116 on ClinicalTrials.gov